Microport Scientific (MCRPF) 0.4800 $MCRPF
MediPoint: Coronary Stents - US Analysis and Market Forecasts
M2 - Thu Dec 04, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/xrr3sw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - US Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Each year, millions of individuals are affected by CAD worldwide. Given the high burden of the disease, it is important to develop innovative technologies that can improve outcomes and disease management. Stenting for coronary applications has been widely adopted in clinical practice worldwide, and can be used in a wide range of indications. By 2020, the coronary stents market for BMS and DES is estimated to be over $5.61 billion. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/xrr3sw/medipoint
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
MediPoint: Coronary Stents - Current and Future Players
M2 - Thu Dec 04, 4:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/vrst8n/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Current and Future Players" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation. Scope - Investigation of current and future market competition for Coronary Stents. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Competitive Assessment 4 Pipeline Products 5 Current and Future Players 6 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/vrst8n/medipoint
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts
M2 - Thu Dec 04, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/8b8djj/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the South America Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in South America Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biomedica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/8b...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts
M2 - Thu Dec 04, 3:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/fxpfd4/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the APAC Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the APAC Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura - Aptus - B. Braun - Bolton - Braile Biomedica - Cardiatis - Cook - Endologix - Getinge - Gore - Grikin Advanced Materials - Johnson & Johnson's - Jotec - LeMaitre Vascular - Lifetech - Lombard - Medtronic - MicroPort Scientific - Nano Endoluminal - Terumo - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material For more information visit http://www.researchandmarkets.com/research/fx...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), LMAT: 7.66 (+0.08)
MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts 2013-2020
M2 - Mon Nov 24, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/lvjkp8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. The US market is the largest market for aortic stent grafts, accounting for more than 40% of the global market. The US market is very similar to that of the global market with regard to the trends in market share. Gore Medical remains the leader in the US for both the EVAR and TEVAR markets. These three companies also offer market leading products for treating AAA and TAA, ensuring long-term, effective solutions to patients. Scope - An overview of Aortic Stent Grafts, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US Aortic Stent Grafts market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Aortic Stent Grafts. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Aortic Stent Grafts sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/lv...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
MediPoint: Coronary Stents - Global Analysis and Market Forecasts to 2020 for the $5.6 Billion Industry
M2 - Fri Nov 21, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/dx86qv/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Global Analysis and Market Forecasts" report to their offering. Coronary Stent Sales by Region Coronary stents can be used for a wide range of indications in coronary artery disease (CAD), including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions. Coronary stents can improve the clinical outcomes for all of these indications as well as quality of life for patients suffering from this debilitating disease. In 2013, sales of DES and BMS in the 10MM were $4.89 billion. The authors estimates the 2014 sales of DES and BMS in the 10MM to be $4.99 billion. By 2020, sales of coronary stents, including bare metal and drug-eluting stents, will grow to $5.62 billion, at a Compound Annual Growth Rate (CAGR) of 2.0%. To date, BAS have not received regulatory approval and been launched in the US, Japanese, and Chinese markets, but are expected to enter these markets in the near future. Of the 10MM covered in the report, the US currently has and will continue to have the largest share in the coronary stents market. Together, the US, the 5EU countries, and Japan will account for 64% of the coronary stents market for BMS and DES in 2020. Collectively, the 5EU countries are forecast to have only 10% market share in the future. Among the emerging markets, China has captured significant market share, which is expected to increase in the future. The emerging markets, including Brazil, China, and India, are expected to demonstrate the greatest growth in the market over the forecast period and will serve as an outlet of expansion for stent manufacturers to increase their global presence. The key drivers for the coronary stents market during the forecast period are: - The rising prevalence of CAD in the major markets covered in this report - The need for effective therapies that reduce the risk of complications, such as restenosis (re-narrowing of the coronary artery), chronic inflammation, and thrombosis, and the need for target lesion revascularization (TLR) associated with bare metal and drug-eluting stenting - The cost savings for healthcare payers resulting from the reduced need for repeat revascularization procedures and prolonged dual antiplatelet therapy - Reducing the need for stent-in-stent procedures and improving the technical feasibility of future interventions - Innovations in stent technology with regard to the platform, material, and coating - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India - The approval and launch of BAS, such as the Absorb BVS, in the US, Japan, and China Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina For more information visit http://www.researchandmarkets.com/research/dx86qv/medipoint
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
MediPoint: Aortic Stent Grafts - Current and Future Players
M2 - Tue Nov 18, 8:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/pk7mdq/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Current and Future Players" report to their offering. The report identifies and analyzes the key companies shaping and driving the Aortic Stent Grafts market. The report provides insight into the competitive Aortic Stent Grafts landscape, including new companies entering the market and pipeline products in development. Scope - Investigation of current and future market competition for Aortic Stent Grafts. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Aortic Stent Grafts in clinical practice. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Competitive Assessment 4 Pipeline Assessment 5 Current and Future Players 6 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/pk...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
Global Intracranial Stents Market Outlook 2018
M2 - Tue Oct 21, 4:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qlhkpr/global) has announced the addition of the "Global Intracranial Stents Market 2014-2018" report to their offering. The Global Intracranial Stents market to grow at a CAGR of 18.75% over the period 2013-2018 Intracranial stents are stainless steel mesh-like tubes with anatomic features to achieve a perfect combination of radial strength and flexibility. Intracranial stents are used in the treatments of cerebral aneurysms, intracranial aneurysms, and intracranial atherosclerosis that cause about eight percent of all ischemic strokes. One key trend in the market is the rise in demand for intracranial stenting procedures for aneurysm repair. The introduction of new intracranial devices with flow-diverters is feasible and effective with high complete occlusion rates, and intraoperative neurophysiological monitoring systems help as a tool for continuous functional monitoring of patients undergoing large-caliber vessel EC-IC bypass surgery. According to the report, the rise in the incidence of cerebral and other diseases, such as obesity and diabetes, is one of the major drivers of the market. Increasing incidence of aneurysms among people mainly aged above 45 years has led to an increase in the use of intracranial stenting procedures, thereby contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the risk of complication, such as bleeding, chronic inflammation, in-stent restenosis, and thrombosis, during neurovascular/cerebrovascular procedures. Key Vendors - Covidien - DePuy Synthes - Medtonic - MicroPort Scientific - OBEX Medical - Stryker Other Prominent Vendors - Abbott Laboratories - Admedes Schuessler - BALT Extrusion - Cardiatis - Penumbra Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Stents - Geographical Segmentation - Buying Criteria - Late-stage Pipeline Products - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/qlhkpr/global
ABT: 46.09 (+0.87)
Aortic Stent Grafts - Global Analysis and Market Forecasts for the $1.2 Billion Industry
M2 - Mon Oct 20, 8:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/snm5b8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts" report to their offering. The total aortic stent graft sales market in 2013 was estimated to be $1,224m across the 10MM By the end of the forecast, the stent graft sales market will grow to over $1,930m, with a Compound Annual Growth Rate (CAGR) of 6.7%. This report focuses on the aortic stent graft implant market for abdominal and thoracic aneurysms. The abdominal aortic market comprises about 80-90% of the market, with the niche market being the thoracic one. The thoracic aneurysm repair market is still a young market where there is a strong pipeline of products from both the large manufacturers and small emerging players. For most manufacturers, following the successful launch of an AAA product, the thoracic stent graft segment presents the opportunity with the most unmet needs for pursuit. The US market consists of the largest portion of the aortic stent graft market. The US and European Union (EU) combined formed close to 70% of the global share in 2013. In the remaining markets, Japan is the largest with China and Brazil to follow. India is by far, the smallest market. The EU is technologically the most advanced market, with the best availability of fenestrated and custom stent grafts on the market. The emerging markets see the most open surgical procedures, but stent use is restricted due to the cost of the products and procedures. As training programs for surgeons increase and product prices decrease, the emerging markets will present a strong opportunity for additional revenue for manufacturers. The overall CAGR across all 10 markets is 6.7%, with Japan and China representing the biggest growth opportunities. The growing concerns for multinational companies reside with the need to better target the fast-growing markets and the need to continue to be the leader in development to combat the threat of rising local manufacturers. The key drivers for the market in the forecast are: - The growing prevalence of aortic aneurysms along with the aging population across the globe with hypertension and obesity. - The growing technological advancement in minimally invasive procedures and the desire to eliminate the need for open surgical procedures for aneurysms. - The major underserved population for minimally invasive aneurysm treatment in the emerging markets that is driving the procedural numbers up. - The unmet need for better clinical outcomes and long-term studies to reduce the risk of endoleaks and other complications. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Cook Medical - Endologix - Gore Medical - Medtronic - Terumo Corporation - Altura Medical - Aptus Endosystems - Bolton Medical - Braile Biom?dica - B. Braun - Cardiatis - LeMaitre Vascular - Lifetech Scientific - Getinge Group - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - Lombard Medical - MicroPort Scientific Corporation - Nano Endoluminal - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/sn...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
China Orthopedic Instrument Industry Report, 2014-2017
PR Newswire - Thu Oct 02, 2:44PM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
MDT: 75.26 (+0.33), SYK: 94.51 (+1.14)
China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017
PRWeb - Fri Aug 22, 6:16AM CDT
Being optimistic about the bright future of the Chinese orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.
MDT: 75.26 (+0.33), SYK: 94.51 (+1.14)
China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com
PRWeb - Fri Aug 22, 1:31AM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
MDT: 75.26 (+0.33), SYK: 94.51 (+1.14)
Wright Medical Group, Inc. Reports 2014 Second Quarter Financial Results
Business Wire - Tue Aug 05, 3:00PM CDT
--Second Quarter Sales from Continuing Operations Increase 19% As Reported and 19% Constant Currency
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Coronary Stents Market - Global Forecast to 2019
M2 - Mon Jul 28, 5:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bczzxn/coronary_stents) has announced the addition of the "Coronary Stents Market - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019" report to their offering. A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or made of biodegradable materials. Coronary stents are utilized during percutaneous coronary interventions (PCIs) for the treatment of patients suffering from various coronary artery diseases (CADs) such as acute myocardial infarction, angina pectoris and others. At present, several researches are being conducted in the field of coronary stenting, in order to minimize side effects such as restenosis and thrombosis. Certain new and advanced coronary stents such as bio-absorbable stents have been commercialized in the global market, which demonstrate very less or no common side effects of coronary stenting. The market for coronary stents can be broadly classified into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. In 2011, the drug eluting stents segment held the largest share of the global coronary stents market, followed by the bare metal stents market. During the forecast period 2013 to 2019, the demand for bare metal stents is expected to be low and its overall growth will be offset by the increasing demand for other stent variants, mainly bio-absorbable stents. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Coronary Stents Market Overview Chapter 4 Global Coronary Stents Market, by Product Type Chapter 5 Global Coronary Stents Market: Pipeline Overview Chapter 6 Global Coronary Stents Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - amg International GmbH - B. Braun Melsungen AG - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cook Medical, Inc. - Johnson & Johnson - Medtronic, Inc. - MicroPort Scientific Corporation - STENTYS SA - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/bc...ary_stents
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33)
Global Electrophysiology Ablation Catheters Market 2014-2018
M2 - Wed Jul 09, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpds69/global) has announced the addition of the "Global Electrophysiology Ablation Catheters Market 2014-2018" report to their offering. Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote irregular cardiac rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias can be of several types, including atrial fibrillation, atrial flutter, and supraventricular tachycardia. Key Regions: - Americas - EMEA - APAC Key Vendors: - Boston Scientific Corp. - Johnson & Johnson - Medtronic Inc. - St. Jude Medical Inc. Other Prominent Vendors: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - VIMECON GmbH Key Market Drivers: - Growing Incidence of Cardiac Arrhythmias. - For a full, detailed list, view the report. Key Market Challenges: - Presence of Substitutes. - For a full, detailed list, view the report. Key Market Trends: - High Adoption of Irrigated-tip EP Ablation Catheters. - For a full, detailed list, view the report. Key Questions Answered in this Report: - What will the market size be in 2018 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Technology 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - Boston Scientific Corp. - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - Johnson & Johnson - Medtronic Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - St. Jude Medical Inc. - VIMECON GmbH For more information visit http://www.researchandmarkets.com/research/zpds69/global
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65), MDSY: 2.97 (+0.02), EW: 134.23 (+1.89), ATRC: 18.86 (+0.04)
MediPoint: Coronary Stents - US Analysis and Market Forecasts
M2 - Thu Dec 04, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/xrr3sw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - US Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Each year, millions of individuals are affected by CAD worldwide. Given the high burden of the disease, it is important to develop innovative technologies that can improve outcomes and disease management. Stenting for coronary applications has been widely adopted in clinical practice worldwide, and can be used in a wide range of indications. By 2020, the coronary stents market for BMS and DES is estimated to be over $5.61 billion. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/xrr3sw/medipoint
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
MediPoint: Coronary Stents - Current and Future Players
M2 - Thu Dec 04, 4:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/vrst8n/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Current and Future Players" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation. Scope - Investigation of current and future market competition for Coronary Stents. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Competitive Assessment 4 Pipeline Products 5 Current and Future Players 6 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/vrst8n/medipoint
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts
M2 - Thu Dec 04, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/8b8djj/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the South America Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in South America Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biomedica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/8b...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts
M2 - Thu Dec 04, 3:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/fxpfd4/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the APAC Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the APAC Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura - Aptus - B. Braun - Bolton - Braile Biomedica - Cardiatis - Cook - Endologix - Getinge - Gore - Grikin Advanced Materials - Johnson & Johnson's - Jotec - LeMaitre Vascular - Lifetech - Lombard - Medtronic - MicroPort Scientific - Nano Endoluminal - Terumo - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material For more information visit http://www.researchandmarkets.com/research/fx...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), LMAT: 7.66 (+0.08)
MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts 2013-2020
M2 - Mon Nov 24, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/lvjkp8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. The US market is the largest market for aortic stent grafts, accounting for more than 40% of the global market. The US market is very similar to that of the global market with regard to the trends in market share. Gore Medical remains the leader in the US for both the EVAR and TEVAR markets. These three companies also offer market leading products for treating AAA and TAA, ensuring long-term, effective solutions to patients. Scope - An overview of Aortic Stent Grafts, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US Aortic Stent Grafts market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Aortic Stent Grafts. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Aortic Stent Grafts sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/lv...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
MediPoint: Coronary Stents - Global Analysis and Market Forecasts to 2020 for the $5.6 Billion Industry
M2 - Fri Nov 21, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/dx86qv/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Global Analysis and Market Forecasts" report to their offering. Coronary Stent Sales by Region Coronary stents can be used for a wide range of indications in coronary artery disease (CAD), including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions. Coronary stents can improve the clinical outcomes for all of these indications as well as quality of life for patients suffering from this debilitating disease. In 2013, sales of DES and BMS in the 10MM were $4.89 billion. The authors estimates the 2014 sales of DES and BMS in the 10MM to be $4.99 billion. By 2020, sales of coronary stents, including bare metal and drug-eluting stents, will grow to $5.62 billion, at a Compound Annual Growth Rate (CAGR) of 2.0%. To date, BAS have not received regulatory approval and been launched in the US, Japanese, and Chinese markets, but are expected to enter these markets in the near future. Of the 10MM covered in the report, the US currently has and will continue to have the largest share in the coronary stents market. Together, the US, the 5EU countries, and Japan will account for 64% of the coronary stents market for BMS and DES in 2020. Collectively, the 5EU countries are forecast to have only 10% market share in the future. Among the emerging markets, China has captured significant market share, which is expected to increase in the future. The emerging markets, including Brazil, China, and India, are expected to demonstrate the greatest growth in the market over the forecast period and will serve as an outlet of expansion for stent manufacturers to increase their global presence. The key drivers for the coronary stents market during the forecast period are: - The rising prevalence of CAD in the major markets covered in this report - The need for effective therapies that reduce the risk of complications, such as restenosis (re-narrowing of the coronary artery), chronic inflammation, and thrombosis, and the need for target lesion revascularization (TLR) associated with bare metal and drug-eluting stenting - The cost savings for healthcare payers resulting from the reduced need for repeat revascularization procedures and prolonged dual antiplatelet therapy - Reducing the need for stent-in-stent procedures and improving the technical feasibility of future interventions - Innovations in stent technology with regard to the platform, material, and coating - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India - The approval and launch of BAS, such as the Absorb BVS, in the US, Japan, and China Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina For more information visit http://www.researchandmarkets.com/research/dx86qv/medipoint
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
MediPoint: Aortic Stent Grafts - Current and Future Players
M2 - Tue Nov 18, 8:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/pk7mdq/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Current and Future Players" report to their offering. The report identifies and analyzes the key companies shaping and driving the Aortic Stent Grafts market. The report provides insight into the competitive Aortic Stent Grafts landscape, including new companies entering the market and pipeline products in development. Scope - Investigation of current and future market competition for Aortic Stent Grafts. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Aortic Stent Grafts in clinical practice. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Competitive Assessment 4 Pipeline Assessment 5 Current and Future Players 6 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/pk...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
Global Intracranial Stents Market Outlook 2018
M2 - Tue Oct 21, 4:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qlhkpr/global) has announced the addition of the "Global Intracranial Stents Market 2014-2018" report to their offering. The Global Intracranial Stents market to grow at a CAGR of 18.75% over the period 2013-2018 Intracranial stents are stainless steel mesh-like tubes with anatomic features to achieve a perfect combination of radial strength and flexibility. Intracranial stents are used in the treatments of cerebral aneurysms, intracranial aneurysms, and intracranial atherosclerosis that cause about eight percent of all ischemic strokes. One key trend in the market is the rise in demand for intracranial stenting procedures for aneurysm repair. The introduction of new intracranial devices with flow-diverters is feasible and effective with high complete occlusion rates, and intraoperative neurophysiological monitoring systems help as a tool for continuous functional monitoring of patients undergoing large-caliber vessel EC-IC bypass surgery. According to the report, the rise in the incidence of cerebral and other diseases, such as obesity and diabetes, is one of the major drivers of the market. Increasing incidence of aneurysms among people mainly aged above 45 years has led to an increase in the use of intracranial stenting procedures, thereby contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the risk of complication, such as bleeding, chronic inflammation, in-stent restenosis, and thrombosis, during neurovascular/cerebrovascular procedures. Key Vendors - Covidien - DePuy Synthes - Medtonic - MicroPort Scientific - OBEX Medical - Stryker Other Prominent Vendors - Abbott Laboratories - Admedes Schuessler - BALT Extrusion - Cardiatis - Penumbra Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Stents - Geographical Segmentation - Buying Criteria - Late-stage Pipeline Products - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/qlhkpr/global
ABT: 46.09 (+0.87)
Aortic Stent Grafts - Global Analysis and Market Forecasts for the $1.2 Billion Industry
M2 - Mon Oct 20, 8:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/snm5b8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts" report to their offering. The total aortic stent graft sales market in 2013 was estimated to be $1,224m across the 10MM By the end of the forecast, the stent graft sales market will grow to over $1,930m, with a Compound Annual Growth Rate (CAGR) of 6.7%. This report focuses on the aortic stent graft implant market for abdominal and thoracic aneurysms. The abdominal aortic market comprises about 80-90% of the market, with the niche market being the thoracic one. The thoracic aneurysm repair market is still a young market where there is a strong pipeline of products from both the large manufacturers and small emerging players. For most manufacturers, following the successful launch of an AAA product, the thoracic stent graft segment presents the opportunity with the most unmet needs for pursuit. The US market consists of the largest portion of the aortic stent graft market. The US and European Union (EU) combined formed close to 70% of the global share in 2013. In the remaining markets, Japan is the largest with China and Brazil to follow. India is by far, the smallest market. The EU is technologically the most advanced market, with the best availability of fenestrated and custom stent grafts on the market. The emerging markets see the most open surgical procedures, but stent use is restricted due to the cost of the products and procedures. As training programs for surgeons increase and product prices decrease, the emerging markets will present a strong opportunity for additional revenue for manufacturers. The overall CAGR across all 10 markets is 6.7%, with Japan and China representing the biggest growth opportunities. The growing concerns for multinational companies reside with the need to better target the fast-growing markets and the need to continue to be the leader in development to combat the threat of rising local manufacturers. The key drivers for the market in the forecast are: - The growing prevalence of aortic aneurysms along with the aging population across the globe with hypertension and obesity. - The growing technological advancement in minimally invasive procedures and the desire to eliminate the need for open surgical procedures for aneurysms. - The major underserved population for minimally invasive aneurysm treatment in the emerging markets that is driving the procedural numbers up. - The unmet need for better clinical outcomes and long-term studies to reduce the risk of endoleaks and other complications. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Cook Medical - Endologix - Gore Medical - Medtronic - Terumo Corporation - Altura Medical - Aptus Endosystems - Bolton Medical - Braile Biom?dica - B. Braun - Cardiatis - LeMaitre Vascular - Lifetech Scientific - Getinge Group - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - Lombard Medical - MicroPort Scientific Corporation - Nano Endoluminal - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/sn...int_aortic
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), EVAR: 5.47 (-0.07), LMAT: 7.66 (+0.08)
China Orthopedic Instrument Industry Report, 2014-2017
PR Newswire - Thu Oct 02, 2:44PM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
MDT: 75.26 (+0.33), SYK: 94.51 (+1.14)
China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017
PRWeb - Fri Aug 22, 6:16AM CDT
Being optimistic about the bright future of the Chinese orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.
MDT: 75.26 (+0.33), SYK: 94.51 (+1.14)
China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com
PRWeb - Fri Aug 22, 1:31AM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
MDT: 75.26 (+0.33), SYK: 94.51 (+1.14)
Wright Medical Group, Inc. Reports 2014 Second Quarter Financial Results
Business Wire - Tue Aug 05, 3:00PM CDT
--Second Quarter Sales from Continuing Operations Increase 19% As Reported and 19% Constant Currency
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Coronary Stents Market - Global Forecast to 2019
M2 - Mon Jul 28, 5:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bczzxn/coronary_stents) has announced the addition of the "Coronary Stents Market - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019" report to their offering. A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or made of biodegradable materials. Coronary stents are utilized during percutaneous coronary interventions (PCIs) for the treatment of patients suffering from various coronary artery diseases (CADs) such as acute myocardial infarction, angina pectoris and others. At present, several researches are being conducted in the field of coronary stenting, in order to minimize side effects such as restenosis and thrombosis. Certain new and advanced coronary stents such as bio-absorbable stents have been commercialized in the global market, which demonstrate very less or no common side effects of coronary stenting. The market for coronary stents can be broadly classified into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. In 2011, the drug eluting stents segment held the largest share of the global coronary stents market, followed by the bare metal stents market. During the forecast period 2013 to 2019, the demand for bare metal stents is expected to be low and its overall growth will be offset by the increasing demand for other stent variants, mainly bio-absorbable stents. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Coronary Stents Market Overview Chapter 4 Global Coronary Stents Market, by Product Type Chapter 5 Global Coronary Stents Market: Pipeline Overview Chapter 6 Global Coronary Stents Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - amg International GmbH - B. Braun Melsungen AG - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cook Medical, Inc. - Johnson & Johnson - Medtronic, Inc. - MicroPort Scientific Corporation - STENTYS SA - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/bc...ary_stents
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33)
Global Electrophysiology Ablation Catheters Market 2014-2018
M2 - Wed Jul 09, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpds69/global) has announced the addition of the "Global Electrophysiology Ablation Catheters Market 2014-2018" report to their offering. Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote irregular cardiac rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias can be of several types, including atrial fibrillation, atrial flutter, and supraventricular tachycardia. Key Regions: - Americas - EMEA - APAC Key Vendors: - Boston Scientific Corp. - Johnson & Johnson - Medtronic Inc. - St. Jude Medical Inc. Other Prominent Vendors: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - VIMECON GmbH Key Market Drivers: - Growing Incidence of Cardiac Arrhythmias. - For a full, detailed list, view the report. Key Market Challenges: - Presence of Substitutes. - For a full, detailed list, view the report. Key Market Trends: - High Adoption of Irrigated-tip EP Ablation Catheters. - For a full, detailed list, view the report. Key Questions Answered in this Report: - What will the market size be in 2018 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Technology 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - Boston Scientific Corp. - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - Johnson & Johnson - Medtronic Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - St. Jude Medical Inc. - VIMECON GmbH For more information visit http://www.researchandmarkets.com/research/zpds69/global
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65), MDSY: 2.97 (+0.02), EW: 134.23 (+1.89), ATRC: 18.86 (+0.04)
